(Q33450683)

26 July 2017

title

Interferon-alpha-2 in the treatment of idiopathic myelofibrosis (English)

1 reference

26 July 2017

1 reference

H L Seewann

1

1 reference

26 July 2017

G Gastl

2

1 reference

26 July 2017

A Lang

3

1 reference

26 July 2017

K Abbrederis

4

1 reference

26 July 2017

J Thaler

5

1 reference

26 July 2017

R Flener

6

1 reference

26 July 2017

C Huber

7

1 reference

26 July 2017

publication date

1 April 1988

1 reference

26 July 2017

1 reference

26 July 2017

volume

56

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

161-163

1 reference

Anemia in primary hyperparathyroidism

26 July 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

[Histopathology and clinical course of chronic, myeloproliferative diseases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Cellular transformation by coordinated action of three peptide growth factors from human platelets

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Osteomyelofibrosis/-sclerosis: a histological and cytogenetic study on core biopsies of the bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

The pathogenesis of myelofibrosis in myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

[alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

A role for 1,25-dihydroxyvitamin D3 in control of bone-marrow collagen deposition?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Annotation. Fibrosis of the bone marrow: content and causes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3355903

12 December 2020

Identifiers

DOI

10.1007/BF00320746

1 reference

26 July 2017

1 reference